Cesca Therapeutics Inc. | Ownership

Companies that own Cesca Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
146,472
0.71%
146,472
0.03%
06/30/2018
BlackRock Fund Advisors
144,226
0.7%
-8,800
0%
06/30/2018
The Vanguard Group, Inc.
128,090
0.62%
42,242
0%
06/30/2018
Citadel Advisors LLC
62,953
0.31%
62,953
0%
06/30/2018
Virtu Financial BD LLC
45,554
0.22%
33,906
0%
06/30/2018
Two Sigma Securities LLC
31,963
0.16%
31,963
0%
06/30/2018
Jane Street Capital LLC
29,174
0.14%
29,174
0%
06/30/2018
UBS Securities LLC
24,023
0.12%
19,070
0%
06/30/2018
Geode Capital Management LLC
18,295
0.09%
18,295
0%
06/30/2018
Creative Planning, Inc.
17,582
0.09%
17,582
0%
06/30/2018

About Cesca Therapeutics

View Profile
Address
2711 Citrus Road
Rancho Cordova California 95742
United States
Employees -
Website http://www.cescatherapeutics.com
Updated 07/08/2019
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.